|
|
|
| The difference and similarity of promoting blood circulation and removing blood stasis in the treatment of acute and chronic cardio-cerebrovascular diseases |
| GUO Sheng1 ZHOU Chengzhi2 |
1.The First Clinical School, Hubei University of Chinese Medicine, Hubei Province, Wuhan 430061, China;
2.Department of Cardiovascular Diseases, Hubei Provincial Hospital of Traditional Chinese Medicine Hubei Academy of Traditional Chinese Medicine Affiliated Hospital of Hubei University of Chinese Medicine, Hubei Province, Wuhan 430061, China |
|
|
|
Abstract Cardio-cerebrovascular diseases is a common disease of middle-aged and elderly people. It has the characteristics of high morbidity, high disability, high mortality, high recurrence rate and many complications, which seriously threatens human life and health. Blood stasis syndrome is a common type of various cardio-cerebrovascular diseases, which runs through the course of various clinical diseases. The method of promoting blood circulation and removing blood stasis is a basic treatment method for treating blood stasis syndrome of traditional Chinese medicine. Due to the clinical course of various cardio-cerebrovascular diseases, the etiology and pathogenesis are different. Traditional Chinese medicine believes that the pathogenic factors of acute blood stasis syndrome mainly include wind pathogen, cold pathogen, and qi reversal, while the chronic pathogenic factors of chronic blood stasis syndrome mainly include phlegm turbidity, virtual, and obstruction. In the treatment, we should dialectically treat the disease, based on the premise of promoting blood circulation and removing blood stasis, combining its specific pathogenic factors, and flexibly combining with other treatments according to the condition to exert better curative effect. This article summarizes the ancient and modern doctors′ understanding of blood stasis syndromes and their treatment methods, and explores the similarities and differences between the method of promoting blood circulation and removing blood stasis in the treatment of blood stasis type acute and chronic cardio-cerebrovascular diseases.
|
|
|
|
|
|
[1] Benjamin EJ，Virani SS，Callaway CW，et al. Heart disease and stroke statistics-2018 update：a report from the american heart association [J]. Circulation，2018，137（12）：e67.
[2] Lovick T. Brain heart interactions in health and disease [J]. Exp Physiol，2014，99（2）：287-288.
[3] 陈伟伟，高润霖，刘力生，等.《中国心血管病报告2017》概要[J].中国循环杂志，2018，33（1）：1-8.
[4] 孙寒梅，李肖亮，陈东英，等.“脑心同治”理论之中西医学考辨[J].中西医结合心脑血管病杂志，2018，16（22）：3383-3386.
[5] 刘玥高，铸烨，付长庚，等.活血化瘀药物防治冠心病：循证与展望[J].中国循证医学杂志，2018，18（11）：1145-1148.
[6] 孙思邈.备急千金要方[M].北京：中国医药科技出版社，2011.
[7] 符茂东，蔡定芳.小续命汤治疗急性中风研究进展[J].山东中医杂志，2016，35（5）：476-478.
[8] 邱敏，孙科，陶劲，等.“中风”病之“内风”病机溯源[J].中国中医基础医学杂志，2016，22（2）：163-164.
[9] 周仲瑛.中医内科学[M].北京：中国中医药出版社，2017：144-145.
[10] 庄享静，贾春华.实验技术介入后中医论治真心痛认知的变迁[J].中华中医药杂志，2015，30（9）：3064-3066.
[11] 宋钊锐，杨炼，许滔.基于《内经》“气脉常通”理论浅谈冠心病心绞痛气滞血瘀型的治法[J].中西医结合心血管病电子杂志，2018，6（17）：11-13.
[12] 陈君.配伍活血化瘀理气类中草药在治疗冠心病心绞痛患者中的应用[J].世界中医药，2017，12（9）：2088-2092.
[13] 李秋艳，王辉，张东，等.翁维良活血化瘀治疗冠心病用药特点[J].中国中医基础医学杂志，2011，17（4）：398.
[14] 吴以岭.络病学[M].北京：中国科学技术出版社，2004：125.
[15] 邱幸凡.络脉络病理论及其临床意义[J].湖北中医杂志，2008，30（6）：22-23.
[16] 彭娟，金庆江，过伟峰.从络虚瘀滞论治颈动脉粥样硬化斑块[J].中西医结合心脑血管病杂志，2019，17（9）：1426-1428.
[17] 高强，张丹丹，王一浩，等.中风恢复期气虚血瘀证理论初探[J].中西医结合心脑血管病杂志，2019，17（7）：1106-1107.
[18] 朱迎君，王永强，王少卿，等.王绵之教授治疗中医脑病遣药用方规律分析[J].中医药学报，2017，45（6）：10-13.
[19] 姜秀新，王朋倩，王茜茜.冠心病从痰瘀论治探析及思考[J].辽宁中医药大学学报，2013，15（3）：62-64.
[20] 朱曾柏.疑难杂症 从痰论治[J].中医杂志，1994，35（5）：270-271. |
|
|
|
